XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Balance (in shares) at Jun. 30, 2022   2,275,029      
Balance at Jun. 30, 2022 $ (30,953) $ 114 $ 64,724 $ 9,455 $ (105,246)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,582)       (2,582)
Foreign currency translation (697)     (697)  
Stock-based compensation 1,522   1,522    
Net restricted stock activity (in shares)   2,722      
Net restricted stock activity (37)   (37)    
Balance (in shares) at Mar. 31, 2023   2,277,751      
Balance at Mar. 31, 2023 (32,747) $ 114 66,209 8,758 (107,828)
Balance (in shares) at Dec. 31, 2022   2,277,645      
Balance at Dec. 31, 2022 (31,635) $ 114 65,707 8,729 (106,185)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,643)       (1,643)
Foreign currency translation 29     29  
Stock-based compensation 502   502    
Net restricted stock activity (in shares)   106      
Net restricted stock activity 0   0    
Balance (in shares) at Mar. 31, 2023   2,277,751      
Balance at Mar. 31, 2023 $ (32,747) $ 114 66,209 8,758 (107,828)
Balance (in shares) at Jun. 30, 2023 2,277,828 2,277,828      
Balance at Jun. 30, 2023 $ (36,730) $ 114 66,764 9,023 (112,631)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (141)       (141)
Foreign currency translation (227)     (227)  
Stock-based compensation 1,292   1,292    
Net restricted stock activity (in shares)   2,120      
Net restricted stock activity $ (16)   (16)    
Balance (in shares) at Mar. 31, 2024 2,279,948 2,279,948      
Balance at Mar. 31, 2024 $ (35,822) $ 114 68,040 8,796 (112,772)
Balance (in shares) at Dec. 31, 2023   2,279,450      
Balance at Dec. 31, 2023 (33,590) $ 114 67,710 9,026 (110,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,332)       (2,332)
Foreign currency translation (230)     (230)  
Stock-based compensation 333   333    
Net restricted stock activity (in shares)   498      
Net restricted stock activity $ (3)   (3)    
Balance (in shares) at Mar. 31, 2024 2,279,948 2,279,948      
Balance at Mar. 31, 2024 $ (35,822) $ 114 $ 68,040 $ 8,796 $ (112,772)